SC 13G/A: Replimune Group, Inc.
Ticker: REPL · Form: SC 13G/A · Filed: 2024-11-04T00:00:00.000Z
Sentiment: neutral
Topics: sc-13g-a
AI Summary
SC 13G/A filing by Replimune Group, Inc..
Risk Assessment
Risk Level: low
From the Filing
EDGAR Filing Documents for 0000932471-24-000693 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0000932471-24-000693 Filing Date 2024-11-04 Accepted 2024-11-04 13:53:18 Documents 1 Document Format Files Seq Description Document Type Size 1 UnitedStates_13G__ReplimuneG.txt SC 13G/A 4050 Complete submission text file 0000932471-24-000693.txt 5576 Mailing Address PO BOX 2600 V26 VALLEY FORGE PA 19482-2600 Business Address 100 VANGUARD BLVD MALVERN PA 19355 6106691000 VANGUARD GROUP INC (Filed by) CIK : 0000102909 (see all company filings) EIN. : 231945930 | State of Incorp.: PA | Fiscal Year End: 1231 Type: SC 13G/A Mailing Address 500 UNICORN PARK WOBURN MA 01801 Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600 Replimune Group, Inc. (Subject) CIK : 0001737953 (see all company filings) EIN. : 822082553 | State of Incorp.: DE | Fiscal Year End: 0331 Type: SC 13G/A | Act: 34 | File No.: 005-90574 | Film No.: 241422429 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)